Literature DB >> 31851651

World Hepatitis Day - July 28, 2019.

.   

Abstract

World Hepatitis Day, observed each year on July 28, was established to raise awareness and promote understanding of viral hepatitis around the world. The theme of this year's World Hepatitis Day is "Invest in Eliminating Hepatitis," underscoring the need to increase commitment for hepatitis response. In 2015, an estimated 257 million persons were living with hepatitis B and 71 million with hepatitis C worldwide (1).

Entities:  

Mesh:

Year:  2019        PMID: 31851651      PMCID: PMC6660101          DOI: 10.15585/mmwr.mm6829a1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


World Hepatitis Day, observed each year on July 28, was established to raise awareness and promote understanding of viral hepatitis around the world. The theme of this year’s World Hepatitis Day is “Invest in Eliminating Hepatitis,” underscoring the need to increase commitment for hepatitis response. In 2015, an estimated 257 million persons were living with hepatitis B and 71 million with hepatitis C worldwide (). Persons who inject drugs are at highest risk for hepatitis C virus (HCV) infection. Globally, an estimated 15.6 million persons aged 15–64 years inject drugs, 52% of whom are HCV-antibody positive (). This issue of MMWR features a report on the progress in the country of Georgia toward prevention and detection of HCV infection, and linkage to treatment, of persons with HCV infection who inject drugs (). Georgia’s hepatitis C elimination program, launched in 2015, was recently named the world’s first Centre of Excellence in Viral Hepatitis Elimination by the European Association for the Study of the Liver International Liver Foundation. Access to hepatitis C testing and treatment for persons who inject drugs is critical to achieving elimination in countries where persons who inject drugs account for a significant proportion of HCV infection. Additional information and resources about viral hepatitis are available at https://www.cdc.gov/hepatitis.
  2 in total

1.  Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.

Authors:  Ketevan Stvilia; Philip R Spradling; Alexander Asatiani; Maka Gogia; Khatuna Kutateladze; Maia Butsashvili; Jaba Zarkua; Tengiz Tsertsvadze; Lali Sharvadze; Maia Japaridze; Tinatin Kuchuloria; Lia Gvinjilia; Irinka Tskhomelidze; Amiran Gamkrelidze; Irma Khonelidze; David Sergeenko; Shaun Shadaker; Francisco Averhoff; Muazzam Nasrullah
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-07-26       Impact factor: 17.586

Review 2.  Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Authors:  Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney
Journal:  Lancet Glob Health       Date:  2017-10-23       Impact factor: 26.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.